Kol cancer study group gets ICMR funding
Published on: Dec. 19, 2025, 11:48 p.m. | Source: Times of India
Kolkata: The Kolkata Gynaecological Oncology Trials and Translational Research Group received ICMR funding for the clinical trial of a PARP inhibitor,.
